Eton Pharmaceuticals, Inc. ETON Accrued Medicaid Rebates Current
Accrued Medicaid Rebates Current at other companies
Other financials
Where this comes from
Reported directly by Eton Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept eton:AccruedMedicaidRebatesCurrent.
The official record: Eton Pharmaceuticals, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eton Pharmaceuticals, Inc.'s accrued medicaid rebates current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eton Pharmaceuticals, Inc.'s accrued medicaid rebates current?
- Eton Pharmaceuticals, Inc. (ETON) reported accrued medicaid rebates current of $11.14M in Q1 2026.
- How has Eton Pharmaceuticals, Inc.'s accrued medicaid rebates current changed year-over-year?
- Eton Pharmaceuticals, Inc.'s accrued medicaid rebates current decreased by 13.9% year-over-year, from $12.94M to $11.14M.
- What is the long-term trend for Eton Pharmaceuticals, Inc.'s accrued medicaid rebates current?
- Over 2 years (2023 to 2025), Eton Pharmaceuticals, Inc.'s accrued medicaid rebates current has grown at a 60.3% compound annual growth rate (CAGR), from $3.63M to $9.32M.
- What does accrued medicaid rebates current mean?
- This represents the estimated current liability for rebates owed to state Medicaid programs resulting from the sale of pharmaceutical products. It reflects the company's obligation to provide price concessions based on government-mandated programs for products dispensed to Medicaid beneficiaries. Monitoring this balance is essential for assessing the impact of government pricing regulations on net revenue and short-term cash flow requirements.